These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8366277)

  • 1. 'Shake-up' in drug industry predicted. Interview by Bob Carlson.
    Watanabe A
    Indiana Med; 1993; 86(4):288-95. PubMed ID: 8366277
    [No Abstract]   [Full Text] [Related]  

  • 2. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming further challenges in the pharma/biotech industry: 2007 update.
    Graul AI; Cruces E; Revel L; Serradell N; Rosa E
    Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Betting on biogenerics.
    Dove A
    Nat Biotechnol; 2001 Feb; 19(2):117-20. PubMed ID: 11175723
    [No Abstract]   [Full Text] [Related]  

  • 6. Reinventing an industry.
    Mandavilli A
    Nature; 2007 Jan; 445(7124):138-9. PubMed ID: 17215817
    [No Abstract]   [Full Text] [Related]  

  • 7. An Indian effort towards affordable drugs: "generic to designer drugs".
    Taneja B; Yadav J; Chakraborty TK; Brahmachari SK
    Biotechnol J; 2009 Mar; 4(3):348-60. PubMed ID: 19296440
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotechs go generic: the same but different.
    Ledford H
    Nature; 2007 Sep; 449(7160):274-6. PubMed ID: 17882194
    [No Abstract]   [Full Text] [Related]  

  • 9. Meeting in the middle.
    Nature; 2007 Jun; 447(7145):629. PubMed ID: 17554281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug discovery: past, present and future.
    Malik NN
    Drug Discov Today; 2008 Nov; 13(21-22):909-12. PubMed ID: 18852066
    [No Abstract]   [Full Text] [Related]  

  • 11. Sandoz sues FDA over delay in first biogeneric approval.
    Fox JL
    Nat Biotechnol; 2005 Nov; 23(11):1327-8. PubMed ID: 16273046
    [No Abstract]   [Full Text] [Related]  

  • 12. Bills target biosimilar drugs.
    Wadman M
    Nature; 2009 Mar; 458(7237):394-5. PubMed ID: 19325595
    [No Abstract]   [Full Text] [Related]  

  • 13. Health care reform: pharmaceutical industry sees itself as 'whipping boy'.
    Gatty B
    Hosp Formul; 1993 Oct; 28(10):872, 871. PubMed ID: 10129137
    [No Abstract]   [Full Text] [Related]  

  • 14. Copycat consolidation.
    Wadman M
    Nature; 2007 Sep; 449(7161):393. PubMed ID: 17898741
    [No Abstract]   [Full Text] [Related]  

  • 15. A few specialty drug prices fall--all generics.
    Manag Care; 2008 Dec; 17(12):46. PubMed ID: 19127766
    [No Abstract]   [Full Text] [Related]  

  • 16. Lessons from Eprex for biogeneric firms.
    Louët S
    Nat Biotechnol; 2003 Sep; 21(9):956-7. PubMed ID: 12949539
    [No Abstract]   [Full Text] [Related]  

  • 17. Handle with care.
    Macilwain C
    Nature; 2006 Apr; 440(7087):990-1. PubMed ID: 16625170
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotech industry struggles with generics approval.
    Knight J
    Nature; 2004 Jun; 429(6992):588. PubMed ID: 15190316
    [No Abstract]   [Full Text] [Related]  

  • 19. Indian biogenerics industry emerges.
    Jayaraman KS
    Nat Biotechnol; 2003 Oct; 21(10):1115-6. PubMed ID: 14520378
    [No Abstract]   [Full Text] [Related]  

  • 20. US policy may encourage counterfeit drugs.
    Bouchie A
    Nat Biotechnol; 2003 Feb; 21(2):121. PubMed ID: 12560826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.